Next Science Ltd (ASX: NXS) Share Price and News
Price
Movement
(20 mins delayed)
52 Week Range
-
1 Year Return
Next Science Ltd Chart and Price Data
Fundamentals Data provided by Morningstar.
Data provided by Morningstar.
Market Cap
$29.22 million
P/E Ratio
N/A
Dividend Yield
0.00%
Shares Outstanding
292.16 million
Earnings per share
-0.049
Dividend per share
N/A
Year To Date Return
-8.70%
Earnings Yield
N/A
Franking
-
Share Price
Day Change
52 Week Range
-
Yesterday's Close
Today's Open
Days Range
-
Volume
Avg. Volume (1 month)
Turnover
as at 24 Feb 3:44pm
Next Science Ltd (ASX: NXS)
Latest News
Share Market News
Why this ASX medical technology share is up 11% today
Share Gainers
Why BHP, Fisher & Paykel Healthcare, Northern Star, & Next Science are racing higher
Share Gainers
Why Clinuvel, Coles, Flight Centre, & Next Science are racing higher
Share Gainers
Why the Next Science share price is storming 15% higher
Share Market News
Here's why Costa, Perenti and Next Science shares are moving higher
Share Gainers
Why this ASX medical technology share is pushing higher today
Share Market News
Why the Next Science share price has surged more than 6% today
Share Gainers
Why Cann, Next Science, Service Stream, & Village Roadshow are pushing higher
Share Gainers
Why the Next Science share price is racing higher today
Share Market News
Why the Paradigm share price is up 250% in 2019
Share Market News
The Next Science share price is tanking on a trading update
Share Market News
Why the Novita Healthcare share price is now up 350% in 3 days
NXS ASX Announcements
An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.
| Date | Announcement | Price Sensitive? | Time | No. of Pages | File Size |
|---|---|---|---|---|---|
| YesNo |
About Next Science Ltd
Next Science Ltd is a medical technology company. It is engaged in the development and commercialization of its proprietary Xbio technology to reduce the impact of biofilm-based infections in human health. Xbio is a non-toxic technology with efficacy in eradicating both biofilm-based and free-floating bacteria. Its products include Bactisure, SURGX, XEPERIENCE and BLASTX. The company derives revenue from North America, New Zealand, and Australia.
NXS Share Price History Data provided by Morningstar.
| Date | Close | Change | % Change | Volume | Open | High | Low |
|---|---|---|---|---|---|---|---|
| 26 Mar 2025 | $0.10 | $-0.01 | -9.09% | 111,779 | $0.11 | $0.11 | $0.10 |
| 25 Mar 2025 | $0.11 | $0.01 | 9.52% | 2,128 | $0.11 | $0.11 | $0.11 |
| 24 Mar 2025 | $0.11 | $-0.02 | -16.67% | 204,816 | $0.11 | $0.11 | $0.11 |
| 21 Mar 2025 | $0.12 | $0.00 | 0.00% | 3,577 | $0.11 | $0.12 | $0.11 |
| 20 Mar 2025 | $0.12 | $0.00 | 0.00% | 3,865 | $0.11 | $0.12 | $0.10 |
| 19 Mar 2025 | $0.12 | $0.01 | 9.09% | 17,824 | $0.11 | $0.12 | $0.10 |
| 18 Mar 2025 | $0.11 | $-0.01 | -8.70% | 10,147 | $0.11 | $0.12 | $0.11 |
| 17 Mar 2025 | $0.12 | $0.01 | 9.52% | 51,672 | $0.12 | $0.12 | $0.12 |
| 14 Mar 2025 | $0.11 | $0.00 | 0.00% | 293,793 | $0.11 | $0.11 | $0.10 |
| 13 Mar 2025 | $0.11 | $0.00 | 0.00% | 35,664 | $0.11 | $0.11 | $0.11 |
| 12 Mar 2025 | $0.10 | $0.00 | 0.00% | 207,616 | $0.10 | $0.11 | $0.10 |
| 11 Mar 2025 | $0.10 | $0.00 | 0.00% | 110,000 | $0.10 | $0.10 | $0.10 |
| 10 Mar 2025 | $0.10 | $0.00 | 0.00% | 1,000 | $0.10 | $0.10 | $0.10 |
| 06 Mar 2025 | $0.10 | $0.00 | 0.00% | 245,824 | $0.11 | $0.11 | $0.10 |
| 05 Mar 2025 | $0.11 | $0.00 | 0.00% | 45,565 | $0.11 | $0.11 | $0.11 |
| 04 Mar 2025 | $0.10 | $0.00 | 0.00% | 477,841 | $0.11 | $0.11 | $0.10 |
| 03 Mar 2025 | $0.11 | $0.00 | 0.00% | 417,321 | $0.11 | $0.11 | $0.11 |
| 28 Feb 2025 | $0.11 | $0.00 | 0.00% | 420,962 | $0.11 | $0.11 | $0.11 |
| 27 Feb 2025 | $0.11 | $0.00 | 0.00% | 1,590,658 | $0.11 | $0.11 | $0.11 |
| 26 Feb 2025 | $0.11 | $-0.01 | -9.09% | 828,117 | $0.11 | $0.11 | $0.11 |
| 25 Feb 2025 | $0.11 | $-0.01 | -8.33% | 1,822,963 | $0.10 | $0.11 | $0.08 |
